Correlation Between Savara and Edgewise Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Savara and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Edgewise Therapeutics, you can compare the effects of market volatilities on Savara and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Edgewise Therapeutics.

Diversification Opportunities for Savara and Edgewise Therapeutics

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Savara and Edgewise is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Savara i.e., Savara and Edgewise Therapeutics go up and down completely randomly.

Pair Corralation between Savara and Edgewise Therapeutics

Given the investment horizon of 90 days Savara Inc is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Savara Inc is 1.63 times less risky than Edgewise Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  687.00  in Edgewise Therapeutics on September 2, 2024 and sell it today you would earn a total of  2,613  from holding Edgewise Therapeutics or generate 380.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Savara Inc  vs.  Edgewise Therapeutics

 Performance 
       Timeline  
Savara Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Edgewise Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Savara and Edgewise Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Savara and Edgewise Therapeutics

The main advantage of trading using opposite Savara and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.
The idea behind Savara Inc and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency